Market Research Logo

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023

Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023

About this market

Technological advances in diagnostics to drive market growth. The diagnostic methods that are currently available in the market include Pap test, colposcopy, and HPV DNA test. Pap test is a screening procedure for cervical cancer, in which the presence of precancerous or cancerous cells is identified on the cervix. Colposcopy is a more advanced technique like a Pap test, which allows the examiner to take abnormal cell tissues from the cervix. Technavio’s analysts have predicted that the human papillomavirus (HPV) therapeutics market will register a CAGR of nearly 9% by 2023.

Market Overview

Advent of vaccines

The global HPV therapeutics market witnessed strong advances in terms of prevention of diseases caused by HPV. This is primarily due to the increasing research on developing highly advanced vaccines with a longer half-life. Vaccines were proved to have strong efficacy toward the prevention of various disease-causing viruses and highly effective toward the prevention of various indications caused by HPV.

Multiple-dose schedules of vaccines

Despite the availability of vaccines for the prevention of indications caused by HPV, the market faces a challenge from their recurring doses. As the vaccines that are currently approved for HPV are developed for administering through invasive methods such as subcutaneous route, the need for multiple doses affects the patient adherence toward the completion of the dose cycle.

For the detailed list of factors that will drive and challenge the growth of the human papillomavirus (HPV) therapeutics market during the 2019-2023, view our report.

Competitive Landscape

The market appears to be fragmented and with the presence of several companies including ALLERGAN and Bausch Health the competitive environment is quite intense. Factors such as the advent of vaccines and the technological advances in diagnostics, will provide considerable growth opportunities to human papillomavirus (HPV) manufactures. ALLERGAN, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, and Merck Sharp & Dohme are some of the major companies covered in this report.


PRESS RELEASE

Technavio Announces the Publication of its Research Report – Global Human Papillomavirus (HPV) Therapeutics Market 2019-2023

Technavio recognizes the following companies as the key players in the global human papillomavirus (HPV) therapeutics market: ALLERGAN, Bausch Health, GlaxoSmithKline, Lee's Pharmaceutical Holdings, and Merck Sharp & Dohme.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is the technological advances in diagnostics.”

According to the report, one of the major drivers for this market is the advent of vaccines.

Further, the report states that one of the major factors hindering the growth of this market is the multiple-dose schedules of vaccines.

Companies Mentioned

ALLERGAN

Bausch Health

GlaxoSmithKline

Lee's Pharmaceutical Holdings

Merck Sharp & Dohme

  • Executive summary
  • Scope of the report
    • Preface
    • Currency conversion rates for US$
  • Market landscape
    • Market ecosystem
      • Table Global pharmaceuticals market
      • Table Segments of global pharmaceuticals market
    • Market characteristics
      • Table Market characteristics
    • Market segmentation analysis
      • Table Market segments
  • Market sizing
    • Market definition
      • Table Market definition - Inclusions and exclusions checklist
    • Market sizing 2018
      • Table Market size 2018
    • Market size and forecast 2018-2023
      • Table Global market: Size and forecast 2018-2023 ($ millions)
      • Table Global market: Year-over-year growth 2019-2023 (%)
  • Five forces analysis
    • Table Five forces analysis 2018
    • Table Five forces analysis 2023
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2018
  • Market segmentation by RoA
    • Table RoA - Market share 2018-2023 (%)
    • Comparison by RoA
      • Table Comparison by RoA
    • Parenteral - Market size and forecast 2018-2023
      • Table Parenteral - Market size and forecast 2018-2023 ($ millions)
      • Table Parenteral - Year-over-year growth 2019-2023 (%)
    • Topical - Market size and forecast 2018-2023
      • Table Topical - Market size and forecast 2018-2023 ($ millions)
      • Table Topical - Year-over-year growth 2019-2023 (%)
    • Market opportunity by RoA
      • Table Market opportunity by RoA
  • Customer landscape
    • Table Customer landscape
  • Geographic landscape
    • Geographic segmentation
      • Table Market share by geography 2018-2023 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2018-2023
      • Table North America - Market size and forecast 2018-2023 ($ millions)
      • Table North America - Year-over-year growth 2019-2023 (%)
    • Europe - Market size and forecast 2018-2023
      • Table Europe - Market size and forecast 2018-2023 ($ millions)
      • Table Europe - Year-over-year growth 2019-2023 (%)
    • Asia - Market size and forecast 2018-2023
      • Table Asia - Market size and forecast 2018-2023 ($ millions)
      • Table Asia - Year-over-year growth 2019-2023 (%)
    • ROW - Market size and forecast 2018-2023
      • Table ROW - Market size and forecast 2018-2023 ($ millions)
      • Table ROW - Year-over-year growth 2019-2023 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity
      • Table Market opportunity
  • Decision framework
  • Drivers and challenges
    • Market drivers
    • Market challenges
      • Table Impact of drivers and challenges
  • Market trends
  • Vendor landscape
    • Overview
      • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
    • Competitive scenario
  • Vendor analysis
    • Vendors covered
      • Table Vendors covered
    • Vendor classification
      • Table Vendor classification
    • Market positioning of vendors
      • Table Market positioning of vendors
    • ALLERGAN
      • Table ALLERGAN - Vendor overview
      • Table ALLERGAN - Product segments
      • Table ALLERGAN - Organizational developments
      • Table ALLERGAN - Geographic focus
      • Table ALLERGAN - Segment focus
      • Table ALLERGAN - Key offerings
      • Table ALLERGAN - Key customers
    • Bausch Health
      • Table Bausch Health - Vendor overview
      • Table Bausch Health - Product segments
      • Table Bausch Health - Organizational developments
      • Table Bausch Health - Geographic focus
      • Table Bausch Health - Segment focus
      • Table Bausch Health - Key offerings
      • Table Bausch Health - Key customers
    • GlaxoSmithKline plc.
      • Table GlaxoSmithKline plc. - Vendor overview
      • Table GlaxoSmithKline plc. - Business segments
      • Table GlaxoSmithKline plc. - Organizational developments
      • Table GlaxoSmithKline plc. - Geographic focus
      • Table GlaxoSmithKline plc. - Segment focus
      • Table GlaxoSmithKline plc. - Key offerings
      • Table GlaxoSmithKline plc. - Key customers
    • Lee's Pharmaceutical Holdings Limited
      • Table Lee's Pharmaceutical Holdings Limited - Vendor overview
      • Table Lee's Pharmaceutical Holdings Limited - Business segments
      • Table Lee's Pharmaceutical Holdings Limited - Organizational developments
      • Table Lee's Pharmaceutical Holdings Limited - Segment focus
      • Table Lee's Pharmaceutical Holdings Limited - Key offerings
      • Table Lee's Pharmaceutical Holdings Limited - Key customers
    • Merck Sharp & Dohme Corp.
      • Table Merck Sharp & Dohme Corp. - Vendor overview
      • Table Merck Sharp & Dohme Corp. - Business segments
      • Table Merck Sharp & Dohme Corp. - Organizational developments
      • Table Merck Sharp & Dohme Corp. - Geographic focus
      • Table Merck Sharp & Dohme Corp. - Segment focus
      • Table Merck Sharp & Dohme Corp. - Key offerings
      • Table Merck Sharp & Dohme Corp. - Key customers
  • Appendix
    • Research methodology
      • Table Validation techniques employed for market sizing
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report